최종 멸균 서비스 시장 : 멸균 방법, 최종사용자, 용도, 지역별(2024-2031년)

Terminal Sterilization Services Market Valuation - 2024-2031

Terminal sterilization services are in high demand owing to the growing need for safe and effective sterilization in the healthcare and pharmaceutical industries. Terminal sterilization is the process of sterilizing things, specifically medical equipment, pharmaceuticals, and packaging, after they have been sealed in their final containers. This guarantees that the items are free of live bacteria, making them suitable for use or ingestion by enabling the market to surpass a revenue of USD 11.96 Billion valued in 2023 and reach a valuation of around USD 26.96 Billion by 2031.

The growing awareness of infection hazards demanding regulatory standards, and the expansion of the pharmaceutical and medical device industries are all driving up demand for terminal sterilization services. These services are becoming increasingly important in ensuring the safety and efficacy of healthcare items reinforcing their key role in public health by enabling the market to grow at a CAGR of 10.70% from 2024 to 2031.

Terminal Sterilization Services Market: Definition/ Overview

Terminal sterilization services refer to the process of sterilizing medical devices, medicines, and other healthcare products in their final packaging. This procedure ensures that any dangerous microorganisms such as bacteria, viruses, and fungi are fully removed or inactivated, rendering the product safe to use. Terminal sterilization is an essential stage in the manufacturing of medical supplies such as surgical equipment, implants, and intravenous fluids. It's named "terminal" because it happens after the product has been entirely packaged and sealed guaranteeing that the contents are sterile until they're opened for usage.

Terminal sterilization services are critical to guaranteeing the safety and efficacy of diverse products, especially in the medical and pharmaceutical industries. One of the principal applications is to sterilize medical devices and tools. These goods which range from surgical equipment to implants must be free of microbiological contamination before they may be used in healthcare facilities. Terminal sterilization requires subjecting these devices to harsh sterilization techniques such as heat, radiation, or chemical sterilization to destroy all forms of microbiological life including bacteria, viruses, and spores.

The future use of terminal sterilization services is expected to increase significantly as the healthcare and pharmaceutical industries expand and prioritize patient safety. Terminal sterilization, or the process of sterilizing products in their final packaging ensures that medical equipment, medications, and other healthcare supplies are free of hazardous bacteria before reaching patients.

Will the Growing Need for Sterilization Services Drive the Terminal Sterilization Services Market?

The Terminal Sterilization Services Market is predicted to develop significantly due to increased demand for sterilization services in a variety of industries including healthcare and pharmaceutical. One of the key factors is the increasing number of surgical procedures performed worldwide. According to the World Health Organization (WHO), over 234 million major surgical procedures are conducted globally each year. To avoid healthcare-associated infections (HAIs), strict sterilization techniques are required due to the high volume of surgeries. According to the Centers for Disease Control and Prevention (CDC), approximately one in every 31 hospital patients experiences at least one HAI on any given day emphasizing the crucial need for adequate sterilization services.

Another significant driver is the growing pharmaceutical and biotechnology industries which require sterile manufacturing facilities and product sterilization. The IQVIA Institute for Human Data Science estimates that the global pharmaceutical market will be worth USD 1.5 Trillion by 2023. This expansion is complemented by tougher regulations governing product safety and quality. For example, the United States Food and Medicine Administration (FDA) has introduced more stringent rules for sterile medicine manufacture, as detailed in its 2018 draft guidance on sterilization techniques. Furthermore, the COVID-19 pandemic has raised awareness of the necessity of sterilization in limiting disease transmission accelerating market growth.

Will the Complexity of Operations Hamper the Terminal Sterilization Services Market?

The intricacy of operations in terminal sterilization services is a significant barrier to market expansion. Terminal sterilization procedures necessitate careful control over a variety of factors such as temperature, pressure, time, and humidity which can be difficult to maintain consistently between product kinds and batches. According to World Health Organization (WHO) research almost 10% of medical equipment fail sterilization processes due to operational difficulties posing possible safety issues and increasing expenses. The Food and Drug Administration (FDA) claimed that between 2015 and 2020, there were over 200 recalls due to sterilization failures emphasizing the difficulties associated with maintaining sterility assurance standards.

Furthermore, the increasing diversity of materials used in medical devices and medications adds to operational complexity. A study published in the Journal of Hospital Infection discovered that approximately 30% of healthcare facilities had difficulty identifying acceptable sterilization methods for innovative materials and sophisticated device designs. The European Medicines Agency (EMA) predicts that validating sterilization techniques for new materials might take up to 18 months possibly delaying product launches and market entrance. Furthermore, the strict regulatory requirements imposed by organizations such as the FDA and EMA involve substantial documentation and validation processes which can be time-consuming and resource-intensive. According to a poll conducted by the International Association for Healthcare Central Service Materiel Management (IAHCSMM), 65% of sterilization specialists see regulatory compliance as a significant concern.

Category-Wise Acumens

Will Innovation in Sterilization Techniques Influence the Application Segment?

The medical devices market is expected to dominate the market over the forecast period . This dominance stems from the important necessity to ensure that medical items such as surgical tools, implants, and diagnostic equipment are clear of any microbial contamination before being used in medical procedures. To ensure patient safety and avoid healthcare-associated infections, health authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strong regulatory requirements and standards on sterilizing operations. As the complexity and variety of medical equipment evolve, there is a growing demand for specialist sterilization services capable of handling various materials and intricate designs.

The medical devices segment benefits from constant innovation in sterilizing processes that are tailored precisely to the specialized needs of medical equipment. For example, the increased use of minimally invasive surgical equipment and advanced implants needs sterilization technologies that can provide complete disinfection without risking the device's integrity or operation. To address these needs, sterilization service providers are investing in cutting-edge technology like ethylene oxide (ETO), gamma irradiation, and electron beam sterilization. The emphasis on maintaining the highest levels of hygiene and sterility in healthcare settings, combined with the ongoing introduction of new and advanced medical devices, assures that this segment will continue to drive expansion in the Terminal Sterilization Services Market.

Will Versatility and Effectiveness Drive Growth in the Sterilization Method Segment?

Ethylene Oxide (ETO) sterilization is the most used procedure. This dominance stems partly from its versatility and efficacy in sterilizing a wide range of materials particularly those susceptible to heat and moisture. ETO sterilization is commonly used for medical devices, surgical instruments, and other healthcare products that cannot tolerate the high heat and moisture found in conventional sterilizing procedures such as steam. Its ability to penetrate intricate gadgets and packaging without destroying the materials makes it a popular choice among manufacturers. Furthermore, ETO sterilization is efficient against a wide range of pathogens including bacteria, viruses, and fungi, providing the maximum level of sterility for vital medical products.

This broad efficacy combined with its compatibility with a wide range of materials strengthens its market leadership. The prevalence of ETO sterilization is reinforced by its widespread use in the healthcare business which is heavily regulated and demands stringent sterilizing requirements. Despite worries about the environmental and safety dangers associated with ETO gas such as potential carcinogenic consequences, the technology is nevertheless commonly employed since alternative sterilizing procedures cannot yet match its efficacy and material compatibility. Gamma and electron beam sterilization are becoming increasingly popular particularly for specific applications such as pharmaceuticals and single-use medical devices but they are frequently limited by equipment size, material compatibility, and the requirement for specialist facilities. ETO's established infrastructure, regulatory approval, and broad applicability ensure that it remains the most popular sterilization technology in the Terminal Sterilization Services Market.

Country/Region-wise Acumens

Will the Advanced Healthcare Infrastructures Drive the Growth in the North American Region?

North America, notably the United States dominates the Terminal Sterilization Services Market owing to its modern healthcare infrastructure and strong regulatory standards. This domination is projected to persist for the foreseeable future. Advanced healthcare infrastructures in North America are fueling growth in the Terminal Sterilization Services Market. The American Hospital Association estimates that there will be 6,093 hospitals in the United States by 2022 resulting in a high need for sterilization services. According to the Centers for Disease Control and Prevention (CDC), nearly one in every 31 hospital patients contracts at least one healthcare-associated infection on any given day underlining the crucial need for proper sterilization.

According to SelectUSA, a government program in the United States, the North American medical equipment market, a significant driver for sterilization services will be worth USD 203.9 Billion by 2022. However, growing concerns about ethylene oxide (EtO) sterilization may act as a market restraint. The Environmental Protection Agency (EPA) has classified it as a carcinogen, and numerous states have imposed or proposed limitations on its use. For example, Illinois approved legislation in 2019 limiting ETO emissions from sterilizing facilities. This regulatory pressure may drive some sterilization service providers to invest in other technologies or encounter operational issues that might influence market growth.

Will the Growing Demand For Reusable Medical Devices Boost the Market in the Asia Pacific Region?

The growing need for reusable medical devices is predicted to greatly enhance the market in Asia Pacific which is projected to be one of the world's fastest-growing marketplaces. This rise in demand is being driven by numerous factors specific to the region including rapid expansion of healthcare infrastructure, an increasing burden of chronic diseases, and rising cost pressures on healthcare systems. Reusable medical devices such as surgical tools, endoscopes, and some diagnostic equipment are cost-effective options for healthcare providers because they can be sterilized and reused. This is especially relevant in the Asia Pacific where many country's healthcare systems are under pressure to deliver high-quality care to a growing population while keeping costs under control.

The Asia-Pacific region is undergoing significant economic growth which has resulted in increasing healthcare spending and facility construction. Countries such as China and India are making significant investments in their healthcare systems to fulfill the demands of their vast populations. As these countries continue to create and modernize their healthcare infrastructure, there is an increasing demand for long-lasting, low-cost medical devices. The region also benefits from a robust industrial base particularly in China, a major producer of medical gadgets. This local production capability contributes to lower prices and greater availability of reusable medical devices.

Competitive Landscape

The Terminal Sterilization Services Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the Terminal Sterilization Services Market.

STERIS, 3M, Getinge, ASP (Fortive), Belimed, Inc. (Metall Zug Group), Sterigenics U.S., LLC - A Sotera Health Company, Fedegari Autoclavi S.p.A., Olympus Corporation, Andersen Sterilizers, Steelco S.p.A.

Latest Developments

In January 2021, STERIS plc agreed to buy Cantel Medical, a provider of infection prevention services and products, through its U.S. subsidiary for about USD 4.6 billion in cash. With this acquisition, the business hoped to provide a diverse variety of infection control and procedural goods and services. Such tactics assist businesses in strengthening their global footprint.

Terminal Sterilization Services Market, By Category

• Sterilization Method
• Ethylene Oxide Sterilization
• Gamma Sterilization
• Electron Beam Sterilization
• End-User
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Medical Device Manufacturers
• Application
• Medical Devices
• Pharmaceuticals
• Lab Equipment
• Geography
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Terminal Sterilization Services Market, By Sterilization Method

• Ethylene Oxide Sterilization
• Gamma Sterilization
• Electron Beam Sterilization

5 Terminal Sterilization Services Market, By Application

• Medical Devices
• Pharmaceuticals
• Lab Equipment

6 Terminal Sterilization Services Market, By End User

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Medical Device Manufacturers

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• BASF SE
• Songwon
• Clariant AG
• Solvay S.A.
• Adeka Corporation
• Addivant
• Milliken Chemical
• Everlight Chemical Industrial Co.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References